In: Main
30 Apr 2010
Do health care providers have a moral and ethical obligation to disclose medical errors honestly and promptly to involved patients and their families?
Thundermist began to implement the satellite distribution system by seeking the state’s approval for remote dispensing of pharmaceuticals. One major challenge was the licensure of the remote dispensing system through the Department of Health’s Board of Pharmacy. The Board members were concerned about the newness of the technology and the security of the system, wondering who would be releasing the medication at the remote facility. Because of a lack of experience withthis technology, few statutes and regulations applied to remote dispensing. This impediment resulted in a five-month delay. The Board of Pharmacy eventually granted approval with a one-year probationary period.
In early 2003, during the planning for the initial in-house pharmacy, Thundermist began formulating plans to expand the availability and access of integrated pharmaceutical care to other underserved sectors in the state. To keep costs as low as possible, the organization began to seek nontraditional ways to accomplish this goal. While attending several health care conferences throughout the country, the CEO became familiar with remote dispensing technology, which was being tried at other health centers nationwide.
In: Main
27 Apr 2010Thundermist has identified several significant health needs and concerns of the medically underserved and has responded with a variety of service options, including:
In: Main
26 Apr 2010
Introduction
The development and application of new and improved technology have had a dramatic impact in the health care field. Advances in diagnostic procedures and devices, medical implants, and surgical techniques are revolutionizing medical care. However, technology has been slow to assist patients living in remote service areas and segments of the population who have historically had difficulty gaining access to quality health care.
In: Disease
24 Apr 2010
Do Selective Beta, Blockers Affect Chronic Heart Failure Related to Rheumatic Fever?
The evidence supports a profound protective effect of beta blockers in their ability to inhibit activation of the neuro-endocrine system in regard to chronic HF: (1) the early activation of the sympathetic nervous system in chronic HF; (2) the beneficial effect of beta blockers on sudden death, especially important in early stages of chronic HF; and (3) the dual inhibitory effect of beta blockers on renin and the sympathetic nervous system.
In: Disease
23 Apr 2010Fundamental Characteristics
Eleven treated patients (25%) and nine control patients (20.5%) did not complete the study. Among the treated patients, five (11.3%) withdrew because of suspected ADEs from generic bisoprolol: weakness, dizziness, and dyspnea. No severe hypotension occurred in either group. Fourteen patients were excluded from the evaluation at follow-up. Seven patients had echocardiographic or 24-hour ECG data of insufficient quality, and seven patients withdrew because of telephone-connection difficulties. Their withdrawal from this study did not affect our conclusions because these patients were equally distributed in the treated and control groups.
Blog invites submissions of review articles, reports on clinical techniques, case reports, conference summaries, and articles of opinion pertinent to the control of pain and anxiety in dentistry.